Optima Health plc (LSE:OPT) has upgraded its profit outlook, expecting adjusted EBITDA for the year ended 31 March 2026 to come in roughly 10% above market expectations. The improved guidance reflects strong trading in the second half and continued progress toward its medium-term goals of £200 million in revenue and £40 million in adjusted EBITDA.
A key driver of the company’s momentum is its recent acquisition of PAM, which management describes as a transformative move. The deal is set to strengthen Optima Health’s standing in the occupational health sector while delivering operational efficiencies and cost synergies. In addition, the resolution of a prior procurement issue, along with related operating income, has provided further support to financial performance.
Despite the positive trajectory, some challenges remain. The business reported negative free cash flow in 2025, and its valuation remains elevated, with a price-to-earnings ratio around 50 despite relatively thin margins. While profitability has improved and leverage remains modest, earnings volatility continues to weigh on investor confidence. Market indicators are also mixed, with neutral momentum and the share price trading below longer-term averages.
More about Optima Health PLC
Optima Health plc is a UK-based provider of occupational health and wellbeing services, combining clinical expertise with technology-driven solutions. The company supports millions of employees through a network of more than 50 clinics and a workforce exceeding 2,000 staff, including around 1,250 clinicians. Its services are delivered across both public and private sectors in the UK, with additional operations in Ireland.
The group focuses on corporate health and wellbeing, using digital platforms alongside clinical delivery to support employers and employees. Its position in the growing occupational health market is supported by its scale, extensive clinic network, and expanding presence across the UK and Ireland.
Leave a Reply